Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) - Contacts and Locations

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

This study has been completed.

Study NCT00034957. Last updated on June 23, 2005. Information provided by Pfizer

Please refer to this study by its ClinicalTrials.gov identifier: NCT00034957

Locations


United States, California
	Research Center
	Greenbrae, California, United States, 94904-2007
	Research Center
	Berkeley, California, United States, 94704
	Research Center
	Rancho Mirage, California, United States, 92270
	Research Center
	Los Angeles, California, United States, 90048

United States, Illinois
	Research Center
	Chicago, Illinois, United States, 60637-1463

United States, Kentucky
	Research Center
	Louisville, Kentucky, United States, 40202

United States, Massachusetts
	Research Center
	West Boylston, Massachusetts, United States, 01583

United States, Michigan
	Research Center
	Ann Arbor, Michigan, United States, 48109

United States, New Hampshire
	Research Center
	Lebanon, New Hampshire, United States, 03756

United States, Tennessee
	Research Center
	Nashville, Tennessee, United States, 37232-6868

United States, Texas
	Research Center
	Arlington, Texas, United States, 76012
	Research Center
	Dallas, Texas, United States, 75390

Sponsors and Collaborators

Pfizer